The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000482369
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
26/02/2026
Date registered
Help: Date registered
17/04/2026
Date last updated
Help: Date last updated
17/04/2026
Date data sharing statement initially provided
Help: Data sharing statement date
17/04/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title
Use of a Mobile Health System (PD-Buddy) Application to Support Patients on Peritoneal Dialysis– A Feasibility Randomised Controlled Trial
Scientific title
A pilot randomised control trial to assess feasibility of comparing an electronic patient monitoring portal versus usual care in patients on peritoneal dialysis
Additional trial identifiers [1] 316055 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Peritoneal dialysis 340852 0
Kidney failure 340853 0
Condition category
Condition code
Renal and Urogenital 337013 337013 0 0
Kidney disease

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Use of a mobile application - PD BUDDY - by

1. Patients - to record patient level observations at daily intervals (including weight, blood pressure, oedema) symptoms (including shortness of breath, exercise tolerance), and therapy level covariates (type of peritoneal dialysis fluid, number of exchanges, and ultrafiltration). Access for duration of study - 6 months. Enrolled participants are provisioned by an admin and download the app from their respective app store.

2. Clinicians - to monitor patient observations, symptoms and therapy via a web portal remotely thrice weekly. No application specific alerts.
Intervention code [1] 332675 0
Treatment: Devices
Description of the comparator or control
1. Use of a notebook by patients - to record patient level observations (including weight, blood pressure, oedema) symptoms (including shortness of breath, exercise tolerance), and therapy level covariates (type of peritoneal dialysis fluid, number of exchanges, and ultrafiltration)

2. Clinicians - monitoring patients through ad hoc clinician or patient initiated communication - predominantly telephone calls, but including scheduled and ad-hoc in-person visits to monitor patient observations, symptoms and therapy.
Control group
Active

Outcomes
Primary outcome [1] 343704 0
Feasibility of conducting a pilot randomized controlled trial comparing the use of the PD BUDDy application to usual care of peritoneal dialysis patients for managing peritoneal dialysis regimen and volume status, assessed as 80% of eligible participants recruited
Timepoint [1] 343704 0
12-months from recruitment of last patient
Secondary outcome [1] 455346 0
Self-reported patient quality of life
Timepoint [1] 455346 0
Baseline (Zero months), 3 months, 6 months and the final visit at 9 months.
Secondary outcome [2] 455347 0
Episodes of peritoneal dialysis related peritonitis
Timepoint [2] 455347 0
Assessed every 3-months for 1 year
Secondary outcome [3] 455348 0
Hospitalization
Timepoint [3] 455348 0
Assessed every 3-months for 1 year from recruitment
Secondary outcome [4] 455349 0
Mortality
Timepoint [4] 455349 0
Assessed every 3-months for 1 year from recruitment
Secondary outcome [5] 459207 0
Exit site infections
Timepoint [5] 459207 0
Assessed every 3-months for 1 year from recruitment using

Eligibility
Key inclusion criteria
Adults with kidney failure who were receiving PD or commenced PD at Princess Alexandra Hospital between 1 January 2022 and 31 August 2023.
Patients must own a mobile device,
Patients need to be proficient in English (patient and/or carer),
Patient's need to comply with the study's technological requirements.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
None

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
concealed using sequentially numbered, opaque, sealed envelopes managed by an independent, blinded biostatistician
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
random - using a random number generator
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD

Funding & Sponsors
Funding source category [1] 320655 0
Charities/Societies/Foundations
Name [1] 320655 0
Princess Alexandra research foundation
Country [1] 320655 0
Australia
Primary sponsor type
Hospital
Name
Princess Alexandra Hospital
Address
Country
Australia
Secondary sponsor category [1] 323970 0
None
Name [1] 323970 0
Address [1] 323970 0
Country [1] 323970 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319195 0
Metro South Human Research Ethics Committee
Ethics committee address [1] 319195 0
Ethics committee country [1] 319195 0
Australia
Date submitted for ethics approval [1] 319195 0
13/11/2019
Approval date [1] 319195 0
06/11/2020
Ethics approval number [1] 319195 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 146566 0
Dr Magid Fahim
Address 146566 0
Kidney and Transplant Service, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, QLD 4169
Country 146566 0
Australia
Phone 146566 0
+61 731765080
Fax 146566 0
Email 146566 0
Contact person for public queries
Name 146567 0
Magid Fahim
Address 146567 0
Kidney and Transplant Service, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, QLD 4169
Country 146567 0
Australia
Phone 146567 0
+61 731765080
Fax 146567 0
Email 146567 0
Contact person for scientific queries
Name 146568 0
Magid Fahim
Address 146568 0
Kidney and Transplant Service, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, QLD 4169
Country 146568 0
Australia
Phone 146568 0
+61 731765080
Fax 146568 0
Email 146568 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.